基于共识聚类的CKD患者亚型分型:CRIC研究
该研究对2696例CRIC队列参与者采用无监督共识聚类分析72项基线特征,识别出3个CKD亚组,各亚组在肾脏衰竭、心血管疾病和死亡风险上存在显著差异,提示多维数据分型有助于精准医学。
要点
- 共识聚类可识别3个基线特征不同的CKD亚组。
- 不同亚组进展至肾衰竭、心血管事件和死亡风险不同。
- 相同基线肾功能患者仍存在异质性,支持精准分型。
核心结论
- 共识聚类整合基线临床和实验室指标,揭示与重要临床结局风险显著不同的CKD亚组。
研究设计与样本
- 前瞻性慢性肾功能不全队列(CRIC)研究,纳入2696例参与者,对72项基线特征进行无监督共识聚类。
主要发现
- 聚类1(n=1203)骨密度、心脏和肾脏功能标志物相对较好,糖尿病和肥胖患病率较低,用药较少。
- 聚类2(n=1098)糖尿病和肥胖患病率较高,用药较多。
- 聚类3(n=395)骨密度较差,心脏和肾脏功能标志物不佳,存在炎症。
- 三个亚组与肾衰竭、心血管疾病复合结局和死亡风险不同相关。
- 在基线肾功能相似的预定义亚组中仍出现患者异质性。
关键数值与推荐
- 使用标准化差值±0.3作为截断值展示亚组特征。
临床怎么用
- 临床可考虑用多维基线数据对CKD患者进行亚型识别,以评估不同结局风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: CKD is a heterogeneous condition with multiple underlying causes, risk factors, and outcomes. Subtyping CKD with multidimensional patient data holds the key to precision medicine. Consensus clustering may reveal CKD subgroups with different risk profiles of adverse outcomes. METHODS: We used unsupervised consensus clustering on 72 baseline characteristics among 2696 participants in the prospective Chronic Renal Insufficiency Cohort (CRIC) study to identify novel CKD subgroups that best represent the data pattern. Calculation of the standardized difference of each parameter used the cutoff of ±0.3 to show subgroup features. CKD subgroup associations were examined with the clinical end points of kidney failure, the composite outcome of cardiovascular diseases, and death. RESULTS: The algorithm revealed three unique CKD subgroups that best represented patients' baseline characteristics. Patients with relatively favorable levels of bone density and cardiac and kidney function markers, with lower prevalence of diabetes and obesity, and who used fewer medications formed cluster 1 (n=1203). Patients with higher prevalence of diabetes and obesity and who used more medications formed cluster 2 (n=1098). Patients with less favorable levels of bone mineral density, poor cardiac and kidney function markers, and inflammation delineated cluster 3 (n=395). These three subgroups, when linked with future clinical end points, were associated with different risks of CKD progression, cardiovascular disease, and death. Furthermore, patient heterogeneity among predefined subgroups with similar baseline kidney function emerged. CONCLUSIONS: Consensus clustering synthesized the patterns of baseline clinical and laboratory measures and revealed distinct CKD subgroups, which were associated with markedly different risks of important clinical outcomes. Further examination of patient subgroups and associated biomarkers may provide next steps toward precision medicine.
引用
- Zheng Z, Waikar SS, Schmidt IM, et al. Subtyping CKD Patients by Consensus Clustering: The Chronic Renal Insufficiency Cohort (CRIC) Study. J Am Soc Nephrol. 2021. PMID: 33462081. doi:10.1681/ASN.2020030239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。